Literature DB >> 2703026

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses.

J R Davies1, E A Grilli.   

Abstract

A study of influenza in residential schools provided the opportunity to assess the significance of antibody as a predictor of immunity. Five hundred and fifty-six pupils from 8 schools were included in the investigations, and the outcome for these children in 27 naturally occurring outbreaks of influenza was analysed. The outbreaks comprised 5 caused by strains of influenza A H3N2, 10 caused by strains of influenza A H1N1, and 12 caused by strains of influenza B. On 8 occasions a second outbreak of the same serotype occurred in a school. There was a general correlation between the presence of antibody to the outbreak strain and protection from infection. For each of the three influenza virus serotypes the infection rate in those with no detectable antibody was approximately 80%. Those with past experience of the virus but no antibody to the outbreak strain experienced lower infection rates (62% overall) but the infection rates were lowest in those with intermediate and high level antibody to the challenge strain (18% overall). Vaccine was used by three of the schools. The effect of antibody derived from recent experience, either natural or vaccine-induced, on subsequent challenge with a drifted strain i.e. one showing antigenic drift away from the previous strain, was compared. Intermediate or high level antibody to the challenge strain in those who had experienced a recent natural infection was associated with a low infection rate (9%). A similar level of antibody produced in response to vaccination was associated with a significantly higher infection rate (23%: P less than 0.025).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703026      PMCID: PMC2249427          DOI: 10.1017/s0950268800030004

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  The laboratory surveillance of influenza epidemics in the United Kingdom 1968-1976.

Authors:  M S Pereira; P Chakraverty
Journal:  J Hyg (Lond)       Date:  1977-08

2.  Infection with influenza A H1N1. 1. Production and persistence of antibody.

Authors:  E A Grilli; J R Davies; A J Smith
Journal:  J Hyg (Lond)       Date:  1986-04

3.  Correlation between rate of infection and preexisting titer of serum antibody as determined by single radial hemolysis during and epidemic of influenza A/Victoria/3/75.

Authors:  A Delem; D Jovanovic
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

4.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

5.  The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.

Authors:  J S Oxford; G C Schild; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1979-02

6.  Influenza in the United Kingdom 1982-85.

Authors:  P Chakraverty; P Cunningham; G Z Shen; M S Pereira
Journal:  J Hyg (Lond)       Date:  1986-10

7.  Field trial with human and equine influenza vaccines in children: protection and antibody titres.

Authors:  A Wesselius-de Casparis; N Masurel; K F Kerrebijn
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  Influenza in the United Kingdom 1977-1981.

Authors:  M S Pereira; P Chakraverty
Journal:  J Hyg (Lond)       Date:  1982-06

9.  Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens.

Authors:  A J Smith; J R Davies
Journal:  J Hyg (Lond)       Date:  1976-10

10.  Influenza B at Christ's Hospital: natural antibody to influenza B estimated by radial haemolysis.

Authors:  E A Grilli; J R Davies
Journal:  J Hyg (Lond)       Date:  1981-10
View more
  28 in total

1.  Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding school.

Authors:  E A Grilli; M J Anderson; T W Hoskins
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

2.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

3.  Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.

Authors:  A M Iorio; T Zei; M Neri; L Campitelli; M R Castrucci; I Donatelli
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

Review 4.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

5.  Influenza vaccination in adults with cystic fibrosis.

Authors:  E L Ong; D Bilton; J Abbott; A K Webb; R A McCartney; E O Caul
Journal:  BMJ       Date:  1991-09-07

6.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 7.  Evaluating the case for trivalent or quadrivalent influenza vaccines.

Authors:  David Baxter
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

Review 8.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 9.  Immunobiology of influenza vaccines.

Authors:  Margarita M Gomez Lorenzo; Matthew J Fenton
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

10.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.